Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Taoufik Beitar"'
Autor:
Rémi Letestu, Marouane Boubaya, Virginie Eclache, Christine Le Roy, Florence Ajchenbaum-Cymbalista, Nadine Varin-Blank, Pierre-Antoine Deglesne, Vincent Levy, Taoufik Beitar, Nathalie Chevallier, Maude Quettier
Publikováno v:
Blood. 120:356-365
B-cell antigen receptor (BCR)–mediated signaling plays a critical role in chronic lymphocytic leukemia (CLL) pathogenesis and gives an in vitro survival advantage to B cells isolated from patients with unfavorable prognostic factors. In this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65bd6b77bc0d9b9f226ebb9ac273fce3
https://doi.org/10.1182/blood-2011-12-397158
https://doi.org/10.1182/blood-2011-12-397158
Autor:
Claudine Roger, Nathalie Chevallier, Rémi Letestu, Celia Salanoubat, Florence Ajchenbaum-Cymbalista, Laurence Sanhes, Joelle Nataf, Pierre-Antoine Deglesne, Taoufik Beitar, Fanny Baran-Marszak, Nadine Varin-Blank
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2006, 66 (14), pp.7158-7166. ⟨10.1158/0008-5472.CAN-06-0085⟩
Cancer Research, American Association for Cancer Research, 2006, 66 (14), pp.7158-7166. ⟨10.1158/0008-5472.CAN-06-0085⟩
Despite very similar gene expression profiles, the clinical course of B-cell chronic lymphocytic leukemia (B-CLL) is heterogeneous. Immunoglobulin VH (IgVH) mutational status and expression of B-cell receptor (BCR) signaling mediators have been assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bedcedcf8c5e0985dc8fac75b74e47ad
https://doi.org/10.1158/0008-5472.can-06-0085
https://doi.org/10.1158/0008-5472.can-06-0085
Autor:
Isabelle Clavereau, Florence Cymbalista, Nathalie S. Chevallier, Nadine Varin-Blank, Pierre-Antoine Deglesne, Rémi Letestu, Taoufik Beitar, Valerie Lefebvre, Amalia Vlad, Fanny Baran-Marszak
Publikováno v:
Blood. 108:2803-2803
Chronic lymphocytic leukemia (CLL) is a highly heterogeneous disease in which BCR signaling capacity plays a central role in disease progression. Previously, we have shown that BCR engagement allows the identification of two groups of patients with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::add99b424198552f1f56cc2487fb4702
https://doi.org/10.1182/blood.v108.11.2803.2803
https://doi.org/10.1182/blood.v108.11.2803.2803
Autor:
Le Roy, Christine, Deglesne, Pierre-Antoine, Chevallier, Nathalie, Taoufik, Beitar, Quettier, Maude, Eclache, Virginie, Letestu, Rémi, Lévy, Vincent, Cymbalista, Florence, Varin-Blank, Nadine
Publikováno v:
In Clinical Lymphoma Myeloma and Leukemia October 2011 11 Supplement 2:S194-S195